Special Issue "Virus Infection and Vaccine Design"

A special issue of Biomedicines (ISSN 2227-9059).

Deadline for manuscript submissions: 31 August 2019.

Special Issue Editors

Guest Editor
Prof. Dr. Gustavo Real Soldevilla

Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria (INIA), Madrid, Spain
Website | E-Mail
Phone: +34 913 478 747
Interests: virulence determinants of Influenza viruses; vaccines; innate immunity
Guest Editor
Prof. Dr. Estanislao Nistal-Villán

Universidad CEU San Pablo, Madrid, Spain
Website | E-Mail
Interests: virulence determinants of Influenza viruses; vaccines; innate immunity

Special Issue Information

Dear colleagues,

Infection with viruses is a central point/theme in human health and human-related animal’s health. Some of these pathogens represent life-threating risks or are important sociological and economical risk factors that require special care. Effective vaccines are the best prophylactic measure to control the infection and risk associated with them. Inactivated and attenuated virus vaccines, together with recombinant protein based-vaccines have been the main vaccine strategies to control viral infections. The experience in the use of different vaccines for human and animal treatment as well as the ability to manipulate viral genomes and make a rational design of vaccines based of replicating viruses with specific genome manipulation have revolutionized the field. In addition, our better understanding of the protective immune correlates, which are specific to each type of virus, as well as the immunology associated with the vaccine, has been instrumental in improving in the design of immunogens, adjuvants, inoculation routes and doses, and tools to determine the vaccine efficiency.

In this Issue, we are offering the opportunity to receive manuscripts that address any point related to any form of vaccines, both conventional and experimental, against human and animal viral infections. Topics that will be accepted include the following:

  • Virus attenuation;
  • Recombinant virus and bacteria as vectors for vaccination;
  • Inactivation methods;
  • Epitope design;
  • Adjuvants and antigenic carriers;
  • Vaccination routes, doses and timing

Prof. Dr. Gustavo Real Soldevilla
Prof. Dr. Estanislao Nistal-Villán
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access quarterly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • vaccine
  • attenuation
  • recombinant vaccines
  • adjuvants
  • protective immune correlates

Published Papers

This special issue is now open for submission.
Biomedicines EISSN 2227-9059 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top